RxDoctor Payments DataLook up a doctor →

Cara Stout

Nurse Practitioner · Kingsport, TNNPI 1700320587

Payments from drug & device makers

$70,782in general payments, 2019–2025

Across 1,127 payments — averaging $62.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$55K
  • UCB, Inc.$2K
  • MDD US Operations, LLC$948
  • Novartis$894
  • Lundbeck LLC$810
  • AstraZeneca$775
  • plus $11K from 54 others

What the payments were for

  • Consulting fees$1500%
  • Speaking & faculty fees$50,29071%
  • Travel & lodging$1,1632%
  • Food & beverage$19,07327%
  • Education$1060%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)306$54,901
UCB, Inc.85$1,849
MDD US Operations, LLC40$948
Novartis47$894
Lundbeck LLC58$810
AstraZeneca(2 entities)35$775
Neurelis, Inc.25$736
Biogen32$699
Lilly USA, LLC44$661
Biohaven Pharmaceuticals, Inc.20$462
Genentech USA, Inc.20$407
Pfizer27$389
Neurocrine Biosciences, Inc.21$377
Teva Pharmaceuticals USA, Inc.21$377
EMD Serono, Inc.21$364
Kyowa Kirin, Inc.16$339
Amgen20$312
TG Therapeutics, Inc.13$302
Eisai Inc.15$299
Sanofi14$283
Jazz Pharmaceuticals Inc.12$282
Argenx US, Inc.13$278
Johnson & Johnson13$269
Otsuka America Pharmaceutical, Inc.16$269
Acadia Pharmaceuticals Inc15$248
SK Life Science, Inc.9$208
Amneal Pharmaceuticals LLC11$207
CSL Behring6$171
Scilex Pharmaceuticals Inc.9$165
Biohaven Pharmaceutical Holding Company Ltd.10$162
Grifols USA, LLC9$161
Bristol Myers Squibb8$156
Impel Pharmaceuticals Inc.17$156
Corium, LLC7$149
Catalyst Pharmaceuticals, Inc.6$138
Merz Pharmaceuticals, LLC6$130
Medtronic4$121
Harmony Biosciences LLC4$120
Ipsen Biopharmaceuticals, Inc5$117
Mallinckrodt Hospital Products Inc.6$116
Sunovion Pharmaceuticals Inc.10$109
Sumitomo Pharma America, Inc.9$104
Avanir Pharmaceuticals, Inc.6$103
Axsome Therapeutics, Inc.5$95
Upsher-smith Laboratories LLC4$67
Tanabe Pharma America, Inc.4$54
Alnylam Pharmaceuticals Inc.3$50
E.r. Squibb & Sons, L.L.C.3$48
Supernus Pharmaceuticals, Inc.2$40
Arbor Pharmaceuticals, Inc.2$32
Takeda Pharmaceuticals U.S.A., Inc.1$32
Vanda Pharmaceuticals Inc.1$27
Aprecia Pharmaceuticals, LLC1$22
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$22
Aucta Pharmaceuticals, Inc.1$22
Tonix Medicines, Inc.1$20
Abbott1$20
Hospira, Inc.1$20
Xeris Pharmaceuticals, Inc.1$19
Acorda Therapeutics, Inc1$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$70,782 in reported general payments places this provider in the 95th percentile of 2,662 nurse practitioner providers in Tennessee.

See all nurse practitioner providers in Tennessee

Medicare billing

Part B allowed, 2024
$51,360
Medicare patients
245
Services billed
521

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Kesimpta PenOfatumumab21$253,820
UbrelvyUbrogepant154$228,571
Aimovig AutoinjectorErenumab-Aooe182$150,337
Nurtec OdtRimegepant Sulfate97$135,381
BetaseronInterferon Beta-1b13$126,235
NuplazidPimavanserin Tartrate17$115,745
VumerityDiroximel Fumarate13$110,049
Emgality PenGalcanezumab-Gnlm139$107,163
CopaxoneGlatiramer Acetate16$89,574
BotoxOnabotulinumtoxina60$78,677
Ajovy AutoinjectorFremanezumab-Vfrm71$60,586
AptiomEslicarbazepine Acetate32$56,039
FycompaPerampanel36$46,460
QuliptaAtogepant40$45,290
NuedextaDextromethorphan Hbr/Quinidine23$35,296

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieUbrelvy, Botox, Qulipta, Namzaric$54,901$377,800276 claims
PfizerNurtec Odt, Eliquis$389$153,966115 claims
Acadia Pharmaceuticals IncNuplazid$248$115,74517 claims
BiogenVumerity$699$110,04913 claims
Teva Pharmaceuticals USA, Inc.Copaxone$377$89,57416 claims
Sunovion Pharmaceuticals Inc.Aptiom$109$56,03932 claims
Eisai Inc.Fycompa$299$46,46036 claims
UCB, Inc.Briviact, Nayzilam$1,849$36,96532 claims
Avanir Pharmaceuticals, Inc.Nuedexta$103$35,29623 claims
Arbor Pharmaceuticals, Inc.Horizant$32$11,16111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,662 nurse practitioner providers in Tennessee.

Other nurse practitioner in Kingsport

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →